SAN FRANCISCO, Oct. 3, 2019 /PRNewswire/ -- The global food allergy diagnostics & therapeutics market size is expected to reach USD 4.71 billion by 2026, according to a new report by Grand View Research, Inc., exhibiting a CAGR of 7.4%. The market is expected to grow in the coming years owing to increasing incidence of food allergies coupled with rising demand for products for management of these conditions.

Key suggestions from the report:

• Therapeutics segment dominated the market in 2018 due to growing demand for antihistamines and epinephrine auto-injector
• Diagnostic segment includes instruments, consumables, and services, wherein consumables accounted for the largest share in 2018
• The most common tests used to diagnose food allergies are skin prick tests and blood tests
• Peanut allergen source segment is anticipated to register lucrative growth over the forecast period, owing to novel product launches coupled with rising incidence of peanut allergies worldwide.
• Hospitals & clinics dominated the food allergy diagnostics & therapeutics market in 2018 owing to increase in number of hospitalizations due to severe allergic conditions
• Europe held the largest share in 2018 owing to increase in prevalence as well as awareness about various symptoms of food allergic reactions in this region
• Asia Pacific is anticipated to exhibit significant growth during the forecast period due to rising disposable income and incidence of shellfish allergy
• Some of the key companies are Allergy Therapeutics; Cambridge Allergy Ltd; Astellas Pharma, Inc.; Immunomic Therapeutics, Inc.; bioMérieux SA; Omega Diagnostics Group PLC; and HYCOR Biomedical

Read 120 page research report with ToC on "Food Allergy Diagnostics & Therapeutics Market Size, Share, & Trends Analysis Report By Product Type (Therapeutic), By Allergen Source (Peanut), By End Use (Hospitals & Clinics), By Region, And Segment Forecasts, 2019 - 2026" at: https://www.grandviewresearch.com/industry-analysis/food-allergy-diagnostics-therapeutics-market

There are more than 160 foods that can lead to allergic reactions; however, only 8 most common allergens have been identified by the FDA. These include eggs, milk, peanuts, soy, tree nuts, wheat, shellfish, and fish. Some of the other allergens are corn, meat, gelatin, seeds, spices, and fruits & vegetables. Based on Food Allergy Research and Education (FARE) 2016 data, around 15 million people in the U.S. have food allergy. Ingestion of any of the common allergens might lead to anaphylaxis, a life-threatening allergic reaction, which might further result in anaphylactic shock. Every year, around 2,000 hospitalizations, 30,000 emergency room visits, and 150 deaths due to anaphylaxis are recorded in the U.S.

However, administering epinephrine using an auto-injector during the early stage of anaphylaxis might help avoid any serious complications. Treatment for food allergy costs around USD 25 billion annually in the U.S. Development of cost-effective in vitro diagnostic tests for detection of allergy is expected to fuel the demand for diagnostic products.

Grand View Research has segmented the food allergy diagnostics & therapeutics market on the basis of product type, allergen source, end use, and region:

• Food Allergy Diagnostics & Therapeutics Product Type Outlook (Revenue, USD Million, 2015 - 2026)
• Diagnostic Products
• Instruments
• Consumables
• Services
• Tests Type
• In Vivo/Skin
• Skin Prick Test
• Patch Test
• In Vitro
• Therapeutic Treatment Type
• Antihistamines
• Epinephrine Auto-injector
• Food Allergy Diagnostics & Therapeutics Allergen Source Outlook (Revenue, USD Million, 2015 - 2026)
• Eggs
• Milk
• Peanuts
• Fish
• Shellfish
• Tree Nuts
• Wheat
• Soy
• Others
• Food Allergy Diagnostics & Therapeutics End-use Outlook (Revenue, USD Million, 2015 - 2026)
• Academic Research Institutes
• Hospitals & Clinics
• Diagnostics Laboratories
• Food Allergy Diagnostics & Therapeutics Regional Outlook (Revenue, USD Million, 2015 - 2026)
• North America
• U.S.
• Canada
• Europe
• Germany
• U.K.
• France
• Italy
• Spain
• Russia
• Asia Pacific
• Japan
• China
• India
• South Korea
• Australia
• Singapore
• Latin America
• Brazil
• Mexico
• Argentina
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE

Find more research reports on Pharmaceuticals Industry, by Grand View Research:

• Dilated Cardiomyopathy Market – Dilated cardiomyopathy (DCM) is a cardiac disorder caused by enlargement of heart. The muscular walls of the heart become weak due to enlargement and hence heart is not able to pump blood efficiently.
• Cancer Therapeutics And Biotherapeutics Market – rising demand for targeted drug therapy and the introduction of advanced treatment methods are some of the emerging growth factors for the biotherapeuics market.
• Non-Small Cell Lung Cancer Market – Lung cancer is differentiated in to two types as non small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). Lung cancer is the uncontrolled growth of cells in the lung tissues.

Gain access to Grand View Compass, our BI enabled intuitive market research database of 10,000+ reports

About Grand View Research

Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.

Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc.
Phone: +1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com 
Web: https://www.grandviewresearch.com 
Follow Us: LinkedIn | Twitter

Logo - https://mma.prnewswire.com/media/661327/Grand_View_Research_Logo.jpg  

SOURCE Grand View Research, Inc.